Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Activity of AMD11070 in HIV
NCT00089466Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mavorixafor in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2004; status: completed.
02
Drugs
mavorixafor
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00089466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089466.